Renewable energy is experiencing a transformative phase worldwide, with unprecedented investments, technological advancements, and policy shifts driving the sector forward. As nations strive to meet climate goals and reduce dependency…
Continue readingAustralia has reached the midpoint of the year, and has recorded another strong sales figure, with 119,659 new vehicles delivered in June. We are however seeing conflicting trends across the…
Continue readingI had the privilege of participating in a panel discussion on financial hardship at the recent Australian Banking Association conference in Melbourne. It was a great panel of experts that…
Continue readingUpdates to this research are published monthly. View previous wave The latest edition of Fifth Quadrant’s SME Sentiment Tracker shows that the current economic climate for SMEs remains challenging, with 38%…
Continue readingAt Fifth Quadrant, we are constantly embracing innovative tools and technologies to enhance our market research capabilities and provide clients with a greater level of insight. Accordingly, we are early…
Continue readingAs we prepare to release the 2024 edition of our Corporate Fleet Insights Report, we are excited to share a sneak preview of the high-level themes that are shaping the…
Continue readingAustralia’s automotive industry has continued its record-breaking new vehicle sales streak, reaching an all-time record high for the month of May. Despite April dipping back below 100,000 sales (97,202), May…
Continue readingUpdates to this research are published monthly. View previous wave The latest Fifth Quadrant SME Sentiment Tracker continues to report soft revenues in line with weak economic conditions. 33% report lower…
Continue readingAustralians love their pets, but as the cost of living continues to rise, many are reconsidering their pet related expenses. According to research commissioned by health fund HCF, 4 in…
Continue readingIn our ongoing series on body image and weight issues in Australia, we delve deeper into the use of pharmaceutical interventions like Ozempic and Mounjaro. The GLP1 agonist class of…
Continue reading